Technical Analysis for VACC - Vaccitech plc

Grade Last Price % Change Price Change
D 14.64 0.62% 0.09
VACC closed up 0.62 percent on Friday, October 15, 2021, on 4 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical VACC trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Fell Below 50 DMA Bearish -2.01%
Crossed Above 50 DMA Bullish -4.50%
Lower Bollinger Band Walk Weakness -4.50%
50 DMA Resistance Bearish 1.81%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.81%
Lower Bollinger Band Walk Weakness 1.81%
Outside Day Range Expansion 1.81%
Below Lower BB Weakness 1.81%
Older End-of-Day Signals for VACC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Vaccitech plc Description

Vaccitech plc is a clinical-stage biopharmaceutical company that engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Its therapeutic programs include VTP-300, indicated for the treatment of chronic hepatitis B infection; VTP-200, indicated for the treatment of human papilloma virus infection; VTP-850, indicated for the treatment of prostate cancer; and VTP-600, indicated for the treatment of non-small cell lung cancer. The company's prophylactic programs include VTP-400 for the prevention of herpes zoster or shingles; and VTP-500 for the prevention of Middle East respiratory syndrome. In addition, it is developing AZD1222, a COVID-19 vaccine. Vaccitech plc was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc on March 31, 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, United Kingdom.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Infectious Diseases Cancers Prostate Cancer Non Small Cell Lung Cancer Vaccine Vaccination Medical Research Treatment Of Non Small Cell Lung Cancer Shingles Immunotherapeutics Treatment Of Prostate Cancer Vaccines Prevention Of Infectious Diseases

Is VACC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 17.99
52 Week Low 12.25
Average Volume 18,577
200-Day Moving Average 0.00
50-Day Moving Average 15.14
20-Day Moving Average 15.27
10-Day Moving Average 14.86
Average True Range 0.65
ADX 25.82
+DI 9.60
-DI 15.74
Chandelier Exit (Long, 3 ATRs) 14.55
Chandelier Exit (Short, 3 ATRs) 16.01
Upper Bollinger Bands 16.24
Lower Bollinger Band 14.29
Percent B (%b) 0.18
BandWidth 12.80
MACD Line -0.18
MACD Signal Line -0.09
MACD Histogram -0.0973
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.06
Resistance 3 (R3) 15.06 14.92 14.99
Resistance 2 (R2) 14.92 14.81 14.92 14.97
Resistance 1 (R1) 14.78 14.75 14.78 14.78 14.94
Pivot Point 14.64 14.64 14.64 14.64 14.64
Support 1 (S1) 14.50 14.53 14.50 14.50 14.34
Support 2 (S2) 14.36 14.47 14.36 14.31
Support 3 (S3) 14.22 14.36 14.29
Support 4 (S4) 14.22